NCT05471635 (WORLDCOV) is a clinical trial of COVID-19 Vaccine in COVID-19 Vaccines, sponsored by Alberto Peano.

Who is sponsoring NCT05471635?

NCT05471635 is sponsored by Alberto Peano.

What drugs are being tested in NCT05471635?

Interventions in NCT05471635: COVID-19 Vaccine.

What condition does NCT05471635 study?

NCT05471635 studies COVID-19 Vaccines.

Is NCT05471635 still recruiting?

NCT05471635 is currently status unknown. Last updated 27 July 2022.

Last reviewed 2022-07-27 · How we verify

NCT05471635: WORLDCOV

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Variables Influencing Anti-COVID-19 Vaccinations Around the World: an Analysis Conducted on Aggregated Data Sourced From Institutional Databases to Understand Whether and How Different Variables Could Affect the Vaccine Coverage (WORLDCOV: Worldwide Determinants of COVID-19 Vaccination)

Status unknown Last updated 27 July 2022

What this trial tests

trial testing COVID-19 Vaccine in COVID-19 Vaccines in 205 participants. Status unknown.

Timeline

20 June 2022

Primary endpoint
20 July 2022

20 July 2022

Quick facts

Lead sponsor	Alberto Peano
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	205
Start date	20 June 2022
Primary completion	20 July 2022
Estimated completion	20 July 2022
Sites	1 location across Italy

Drugs / interventions tested

COVID-19 Vaccine (COVID-19 Vaccine) — full drug profile →

Conditions studied

COVID-19 Vaccines — all drugs for COVID-19 Vaccines →

Sponsor

Alberto Peano

Who can join

Eligibility, any sex, with COVID-19 Vaccines. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Vaccination coverage against COVID-19 differs widely between countries: in order to address this public health issue, this observational study seeks to understand whether there are any determinants/predictors. In order to highlight the presence of determinants and their strength in influencing vaccination coverage, all possible socio-demographic, economic, cultural, infrastructural and political variables considered capable of modifying such coverage were selected and analysed.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Determinants of COVID-19 vaccination worldwide: WORLDCOV, a retrospective observational study.
Peano A, Politano G, Gianino MM. · · 2023 · cited 6× · PMID 37719735 · DOI 10.3389/fpubh.2023.1128612

Verify or expand the search:

Other trials of COVID-19 Vaccine

Trials testing the same drug.

NCT06864143 — A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in A · Phase 2 · completed
NCT06683352 — A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People · Phase 1, PHASE2 · completed
NCT06163677 — A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza. · withdrawn
NCT06178991 — A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against CO · Phase 3 · completed
NCT06097273 — A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age · Phase 3 · completed

Other recruiting trials for COVID-19 Vaccines

Currently open trials in the same condition.

NCT06923137 — A Study to Learn About How Well Yearly Updates to the COVID-19 Vaccine Work to Protect People From COVID-19 and How Much · active not recruiting
NCT05556720 — Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Contro · Phase 3 · active not recruiting
NCT05096260 — Getting to Yes, Michigan! (G2YMI) · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05471635 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alberto Peano
Last refreshed: 27 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05471635.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing